Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14

Condition:   Adenoid Cystic Carcinomas of the Salivary Glands
Intervention:   Drug: Lenvatinib
Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2aFXzMI
via IFTTT